Home » Consortium Academic » Hannover Medical School, Germany

Hannover Medical School, Germany

Partner Description

Founded in 1965 the Hannover Medical School (MHH) today became one of the leading university medical institutions in Germany. The Hannover Unified Biobank (HUB) is the central biobank of the MHH. It was established in 2012 to provide the infrastructure for the standardised collection and storage of high quality biosamples and associated data for MHH researchers. Headed by Prof. Dr. Thomas Illig the HUB developed into one of the biggest state of the art clinical biobanks in Germany and is equipped with a modern, high quality and safe biobank infrastructure with focus on a high automation level and standardized processes. Today the HUB administers about 2.88 Mio samples (status January 2020) of all kinds of biomaterial (e.g. body fluids, tissues, cells, microorganisms) of a wide range of diseases from clinical routine procedures, research and clinical studies. The HUB works to the highest quality standards and has been certified according to DIN EN ISO 9001:2015.The ISO certified processes of HUB include sample transport, preparation, and storage as well as associated data management. The HUB is member of the German Center for Lung Diseases (DZL) and the German Center for Infection Research (DZIF) with the DZIF-Transplant cohort. Since 2017 the HUB is a member of the German Biobank Alliance. The alliance partners establish uniform quality standards and make their biosamples available for biomedical research throughout Europe via the European biobank network BBMRI-ERIC.

Role within Project

  • Establishment of a network of disease domain experts who can provide samples to facilitate the sourcing of human-derived immune and tissue samples
  • Setup of a distributed biobank across specific disease areas to facilitate efficient obtainment of samples ethically and under a high level of data protection and privacy
  • Workflows and devices for sample handling and sample logistics for delivering samples with a minimal amount of variance
  • Biobanking of samples generated in experiments in WP 2 – 4